There are two main forms of damage myocardium in diabetes mellitus: diabetychna kardiomiopatiya (Non-Coronary genesis i (ishemic). Vydilyayut, metabolic or metabolic-hipoksychnu stage, which is of specific metabolic disease MC belonging to the secondary metabolic endocrine kardiopatiy, metabolic-ishemichnu stage, infarkt miokarda, dystrophic koronarosklerotychnyy kardioskleroz; diabetychnu autonomous nevropatiyu heart DANS is one of the most serious complications of diabetes, which is diagnosed poorly, may be accompanied by severe postural hypotension, impaired exercise tolerance, be the cause of coronary ischemia, "dumb" MI, syndrome of "sudden" death.

The estimation of dynamics of indicators of daily monitoring of arterial pressure on a background is carried out appointment of Omakor® in patients with type 2 diabetes mellitus with autonomic cardiac neuropathy. It is established that the use of Omakor® is accompanied by a tendency to normalize the averages values ​​of diastolic blood pressure (DBP), time index of BP hypertension, the index of the area of ​​arterial hypertension of DBP, variability of DBP in day and night hours; observed there is a decrease in the severity of symptoms of autonomic imbalance. Combination of detected effects indicates the feasibility of using Omakor® in the treatment of patients with type 2 diabetes mellitus with autonomic cardiac neuropathy.

Biological rhythm control systems are a genetically mediated basis for ensuring the optimal physiological functioning of cells, tissues, organs and systems, which has been reflected. in the presence of dynamic, partially endogenous, ultrashort (less than 20 hours), circadian (20–28 hours) and longer rhythms